Its 2022 disclosure by Coskun and colleagues (Cell Metabolism) marked a deliberate extension of the dual-incretin agonist concept pioneered by tirzepatide, adding glucagon receptor engagement to the pharmacological palette
Your blood sugars improving
This can make a significant difference in approval and ensure your documentation supports medical necessity
Symptoms of low blood sugar include shakiness, sweating, confusion, and irritability
Genetics, diet, activity level, starting weight, metabolic health, and medication adherence all influence your personal response
Biopsy: This is the most accurate way to see changes in fat, inflammation, and fibrosis, but it is invasive, so its not done often in studies